Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002481647 | SCV002791654 | pathogenic | Epilepsy, idiopathic generalized, susceptibility to, 11; Familial hyperaldosteronism type II; Leukoencephalopathy with mild cerebellar ataxia and white matter edema | 2021-09-20 | criteria provided, single submitter | clinical testing | |
Ute Scholl Laboratory, |
RCV000516109 | SCV000606833 | pathogenic | Familial hyperaldosteronism type II | 2017-09-25 | no assertion criteria provided | research | Four independent occurrences of CLCN2 p.Arg172Gln, significant burden of rare variants in CLCN2 in early-onset primary aldosteronism (two de novo), localization of CLCN2 in adrenal zona glomerulosa, electrophysiologic impact of mutant channels and effect on aldosterone synthase expression |
OMIM | RCV000516109 | SCV000803370 | pathogenic | Familial hyperaldosteronism type II | 2021-05-06 | no assertion criteria provided | literature only |